Māori health academic and GP David Tipene-Leach speaking at GP21: Conference for General Practice: “Acknowledge historical trauma in everything you do in the clinic”
From cultural sensitivity to cultural safety via cultural competency, it has been a decades-long journey for health professionals. Editor Barbara Fountain reports from GP21: Conference for General Practice in Wellington last month
Cultural safety can be an empowering approach for all of us
Māori health academic David Tipene-Leach is keen to counter any hesitancy GPs might f
Linda Bryant discusses gout, a chronic long-term condition that is often associated with other diseases, and drug-related morbidity and mortality. As such, gout needs to be addressed holistically as part of the psychosocial medical model
Patients can no longer be started on funded selegiline. Patients who were on selegiline prior to 1 August 2021 will need their prescriptions endorsed to receive subsidised supplies. An alternative MAO-B inhibitor, rasagiline, may be a suitable agent for new patients or those transitioning from selegiline.
This resource provides a timeline for the changes and information about transitioning patients from selegiline. Advice on prescribing rasagiline is also included.